The Definitive Guide to psilocybin microdosing
The present authors carried out an open-label pilot examine that administered psilocybin to fifteen treatment method-resistant tobacco/nicotine-dependent people who smoke, during the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Contributors have been administered ~0.29 mg/kg oral psilocybin to the participant�